THE CYTOTOXICITY EFFECTS OF 177LU-PA-DOTA-HERCEPTIN IN BREAST CANCER CELL LINES

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

RASANEH SAMIRA; JOHARI DAHA FARIBA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: NEW CELLULAR & MOLECULAR BIOTECHNOLOGY JOURNAL Year:2016 | Volume:6 | Issue:24 Page(s): 15-21

Download Full-Text

Persian Verion

View:

881

Download:

Cites:

Information Journal Paper

Title

THE CYTOTOXICITY EFFECTS OF 177LU-PA-DOTA-HERCEPTIN IN BREAST CANCER CELL LINES

Author(s)

RASANEH SAMIRA | JOHARI DAHA FARIBA | Issue Writer Certificate

Keywords

HERCEPTINQ2

BREAST CANCERQ1

LUTETIUMQ1

CYTOTOXICITYQ1

Abstract

Aim and Background: HERCEPTIN is a human monoclonal antibody that is being used in treatment of the BREAST CANCER. In this study, this monoclonal antibody was labeled with LUTETIUM-177 via PA-DOTA chelator and at the first stage its therapeutic effects on SKBR3, MCF7 and A431 BREAST CANCER cell lines was investigated.Material and Methods: The in vitro quality control tests included labeling efficiency, immunoreactivity, in vitro stability in buffer and blood serum were performed. The CYTOTOXICITY effect of the complex was considered upon 168 hours on the SKBR3, MCF7 and A431 BREAST CANCER cell lines.Results: The labeling efficiency was 85±5%. The stability in phosphate buffer and human blood serum was 73±5% and 65±3% respectively up to 96 hours. The immunoreactivity of the complex was 72 ± 8%. It was calculated 5 folds increasing in toxicity of HERCEPTIN-177Lu compared with unlabeled HERCEPTIN on SKBR3 cells.Conclusion: The results showed that this new complex could be a promising candidate for further evaluation in animals and possibly in humans as a new radiopharmaceutical for use in radioimmunotherapy of BREAST CANCER.

Cites

No record.

References

Cite

APA: Copy

RASANEH, SAMIRA, & JOHARI DAHA, FARIBA. (2016). THE CYTOTOXICITY EFFECTS OF ¹⁷⁷LU-PA-DOTA-HERCEPTIN IN BREAST CANCER CELL LINES. NEW CELLULAR & MOLECULAR BIOTECHNOLOGY JOURNAL, 6(24), 15-21. SID. https://sid.ir/paper/204582/en

Vancouver: Copy

RASANEH SAMIRA, JOHARI DAHA FARIBA. THE CYTOTOXICITY EFFECTS OF ¹⁷⁷LU-PA-DOTA-HERCEPTIN IN BREAST CANCER CELL LINES. NEW CELLULAR & MOLECULAR BIOTECHNOLOGY JOURNAL[Internet]. 2016;6(24):15-21. Available from: https://sid.ir/paper/204582/en

IEEE: Copy

SAMIRA RASANEH, and FARIBA JOHARI DAHA, “THE CYTOTOXICITY EFFECTS OF ¹⁷⁷LU-PA-DOTA-HERCEPTIN IN BREAST CANCER CELL LINES,” NEW CELLULAR & MOLECULAR BIOTECHNOLOGY JOURNAL, vol. 6, no. 24, pp. 15–21, 2016, [Online]. Available: https://sid.ir/paper/204582/en

Related Journal Papers